| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/13/2009 | US20090203629 Inhibitors of cathepsin b |
| 08/13/2009 | US20090203628 Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition |
| 08/13/2009 | US20090203627 Specific binding sites in collagen for integrins and use thereof |
| 08/13/2009 | US20090203626 Pediatric Amino Acid Solution for Parenteral Nutrition |
| 08/13/2009 | US20090203624 Alpha-fetoprotein peptides |
| 08/13/2009 | US20090203623 METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST |
| 08/13/2009 | US20090203622 Method of treating metastatic stage prostate cancer |
| 08/13/2009 | US20090203621 Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1 |
| 08/13/2009 | US20090203620 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 08/13/2009 | US20090203619 Artificial platelets |
| 08/13/2009 | US20090203618 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 08/13/2009 | US20090203617 Chimeric peptides for the regulation of gtpases |
| 08/13/2009 | US20090203616 Methods for treating pain and screening analgesic compounds |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203614 Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration |
| 08/13/2009 | US20090203613 Systems and methods for preparing autologous fibrin glue |
| 08/13/2009 | US20090203611 Anti-microbial defensin-related peptides and methods of use |
| 08/13/2009 | US20090203610 Methods of treating obesity or diabetes using nt-4/5 |
| 08/13/2009 | US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases |
| 08/13/2009 | US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis |
| 08/13/2009 | US20090203607 Method And Compositions For Simultaneously Regulating Memory And Mood |
| 08/13/2009 | US20090203606 Systems for and Methods of use of Therapeutic Nutrition for the Management of Age-Associated and Age-Specific Health Conditions of the Elderly |
| 08/13/2009 | US20090203605 Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis |
| 08/13/2009 | US20090203604 Soothing agent and food for treating fatigue |
| 08/13/2009 | US20090203603 Compositions for the Treatment and Prevention of Nephropathy |
| 08/13/2009 | US20090203602 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 08/13/2009 | US20090203601 Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (G-CSF) variant |
| 08/13/2009 | US20090203600 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use |
| 08/13/2009 | US20090203599 N-terminal modified peg-trail, method for preparing and uses thereof |
| 08/13/2009 | US20090203598 Abc transporter ligand |
| 08/13/2009 | US20090203597 Methods to Restore Glycemic Control |
| 08/13/2009 | US20090203596 Phosphatase Inhibitor Protein-1 As A Regulator of Cardiac Function |
| 08/13/2009 | US20090203595 Neuregulin variants and methods of screening and using thereof |
| 08/13/2009 | US20090203594 Anticancer peptide |
| 08/13/2009 | US20090203593 Immunogenic Constructs |
| 08/13/2009 | US20090203592 Infant nutrition with hydrolised proteins |
| 08/13/2009 | US20090203591 Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 08/13/2009 | US20090203590 Method for the inhibition of angiogenesis |
| 08/13/2009 | US20090203589 Chemically modified human growth hormone receptor antagonist conjugates |
| 08/13/2009 | US20090203588 Outcome prediction and risk classification in childhood leukemia |
| 08/13/2009 | US20090203587 Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis |
| 08/13/2009 | US20090203586 Method for ameliorating an inflammatory skin condition |
| 08/13/2009 | US20090203585 Capreomycin derivatives and their use as antibacterials |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090203583 Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity |
| 08/13/2009 | US20090203582 Lysobactin amides |
| 08/13/2009 | US20090203581 Novel Peptides for Use in the Treatment of Obesity |
| 08/13/2009 | US20090203580 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 08/13/2009 | US20090203579 Glycopegylated Granulocyte Colony Stimulating Factor |
| 08/13/2009 | US20090203578 Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use |
| 08/13/2009 | US20090203577 Azepinoindole Derivatives As Pharmaceutical Agents |
| 08/13/2009 | US20090203576 Methods and compositons for pulmonary delivery of insulin |
| 08/13/2009 | US20090203575 metabolic diseases such as lysosomal storage diseases; therapeutic agent and a targeting moiety that binds a mannose-6-phosphate receptor |
| 08/13/2009 | US20090203574 Method for Modulating Hair Growth |
| 08/13/2009 | US20090203573 Use of dietary fibres against muscle wasting |
| 08/13/2009 | US20090203572 Method for in Vitro Molecular Evolution of Protein Function |
| 08/13/2009 | US20090203128 Nogo-Receptors and Methods of Use |
| 08/13/2009 | US20090203124 Mage-a3 peptides presented by hla-dr1 molecules |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203110 COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV |
| 08/13/2009 | US20090203072 Detection for HPV-Induced invasive cancers and their precursor lesions with invasive potential |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090203027 Assays for Detecting T2R76 Taste Modulatory Compounds |
| 08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
| 08/13/2009 | US20090202660 Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation |
| 08/13/2009 | US20090202659 Modulation of Peripheral Clocks in Adipose Tissue |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202628 Nanoparticles for protein drug delivery |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202626 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | US20090202620 Polymer-stabilized liposomal compositions and methods of use |
| 08/13/2009 | US20090202617 Gas based wound and tissue therapeutics |
| 08/13/2009 | US20090202613 Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same |
| 08/13/2009 | US20090202606 Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202585 Tat-based tolerogen compositions and methods for making and using same |
| 08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202574 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202571 Bioreductively-activated prodrugs |
| 08/13/2009 | US20090202565 Torc polynucleotides and polypeptides and method of use |
| 08/13/2009 | US20090202563 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/13/2009 | US20090202555 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202554 Method of modulation of interaction between receptor and ligand |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202551 Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202545 Melanoma biomarker and methods of uses |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202542 Rage protein derivatives |
| 08/13/2009 | US20090202538 F11 receptor (f11r) antagonists as therapeutic agents |
| 08/13/2009 | US20090202535 Method for neutralizing effects of sPLA2 |
| 08/13/2009 | US20090202533 Treatment and prophylaxis of th2 mediated disorders |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202527 Treatment for multiple sclerosis |